REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291 | -24.6% | 27,687 | +81.5% | 0.00% | -50.0% |
| Q2 2023 | $386 | -21.4% | 15,252 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $491 | +74.1% | 15,252 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $282 | -99.9% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $412,000 | +95.3% | 15,252 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $211,000 | -29.0% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $297,000 | +19.3% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | -41.4% | 15,252 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $425,000 | -6.0% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $452,000 | +6.1% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $426,000 | -1.4% | 15,252 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $432,000 | – | 15,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |